3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Interventions
eltrombopag
4
Platelet Transfusion
4
romiplostim
2
Cytarabine
2
Cyclophosphamide
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
sodium thiosulfate
1
pegfilgrastim
1
niraparib
1
fludarabine
1
etoposide phosphate
1
Vorinostat
1
Tranexamic Acid
1
Temozolomide
1
Stem Cell Transplantation
1
Saline Solution
1
Rituximab
1
Radiotherapy
1
Pharmacokinetics
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Comparative Genomic Hybridization
1
Carboplatin
1
Busulfan
1
Aspirin
1
Amplified Fragment Length Polymorphism Analysis
1
Aminocaproic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Thrombocytopenia
×
Pharmacokinetics
×
Clear all
NCT04861181
2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4
Terminated
12 enrolled